Filing Details

Accession Number:
0001203311-21-000038
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-19 19:10:29
Reporting Period:
2021-05-17
Accepted Time:
2021-05-19 19:10:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1060736 Seagen Inc. SGEN Biological Products, (No Disgnostic Substances) (2836) 911874389
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1809717 R Charles Romp 21823 30Th Drive Se
Bothell WA 98021
Evp, Commercial No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-05-17 334 $145.95 43,890 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
  2. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 147 shares acquired under the Amended & Restated 2000 Employee Stock Purchase Plan on January 29, 2021.